306 related articles for article (PubMed ID: 38107516)
1. Causal effects of circulating lipids and lipid-lowering drugs on the risk of urinary stones: a Mendelian randomization study.
Tan Z; Hong J; Sun A; Ding M; Shen J
Front Endocrinol (Lausanne); 2023; 14():1301163. PubMed ID: 38107516
[TBL] [Abstract][Full Text] [Related]
2. Causal effects of circulating lipids and lipid-lowering drugs on the risk of epilepsy: a two-sample Mendelian randomization study.
Liang Z; Zhao L; Lou Y; Liu S
QJM; 2023 Jun; 116(6):421-428. PubMed ID: 36964718
[TBL] [Abstract][Full Text] [Related]
3. Associations of Lipids and Lipid-Lowering Drugs with Risk of Vascular Dementia: A Mendelian Randomization Study.
Zhang X; Geng T; Li N; Wu L; Wang Y; Zheng D; Guo B; Wang B
Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615727
[TBL] [Abstract][Full Text] [Related]
4. Genetic association of lipids and lipid-lowering drugs with sepsis: a Mendelian randomization and mediation analysis.
Lou C; Meng Z; Shi YY; Zheng R; Qian SZ; Pan J
Front Cardiovasc Med; 2023; 10():1217922. PubMed ID: 37621565
[TBL] [Abstract][Full Text] [Related]
5. Lipids, lipid-lowering agents, and inflammatory bowel disease: a Mendelian randomization study.
Tao H; Yu Z; Dong Y; Liu L; Peng L; Chen X
Front Immunol; 2023; 14():1160312. PubMed ID: 37350960
[TBL] [Abstract][Full Text] [Related]
6. The causal effects of lipid traits on kidney function in Africans: bidirectional and multivariable Mendelian-randomization study.
Kintu C; Soremekun O; Kamiza AB; Kalungi A; Mayanja R; Kalyesubula R; Bagaya S B; Jjingo D; Fabian J; Gill D; Nyirenda M; Nitsch D; Chikowore T; Fatumo S
EBioMedicine; 2023 Apr; 90():104537. PubMed ID: 37001235
[TBL] [Abstract][Full Text] [Related]
7. Using genetic variants to evaluate the causal effect of cholesterol lowering on head and neck cancer risk: A Mendelian randomization study.
Gormley M; Yarmolinsky J; Dudding T; Burrows K; Martin RM; Thomas S; Tyrrell J; Brennan P; Pring M; Boccia S; Olshan AF; Diergaarde B; Hung RJ; Liu G; Legge D; Tajara EH; Severino P; Lacko M; Ness AR; Davey Smith G; Vincent EE; Richmond RC
PLoS Genet; 2021 Apr; 17(4):e1009525. PubMed ID: 33886544
[TBL] [Abstract][Full Text] [Related]
8. Association of lipid-lowering drugs with COVID-19 outcomes from a Mendelian randomization study.
Huang W; Xiao J; Ji J; Chen L
Elife; 2021 Dec; 10():. PubMed ID: 34866576
[TBL] [Abstract][Full Text] [Related]
9. Lipid traits and type 2 diabetes risk in African ancestry individuals: A Mendelian Randomization study.
Soremekun O; Karhunen V; He Y; Rajasundaram S; Liu B; Gkatzionis A; Soremekun C; Udosen B; Musa H; Silva S; Kintu C; Mayanja R; Nakabuye M; Machipisa T; Mason A; Vujkovic M; Zuber V; Soliman M; Mugisha J; Nash O; Kaleebu P; Nyirenda M; Chikowore T; Nitsch D; Burgess S; Gill D; Fatumo S
EBioMedicine; 2022 Apr; 78():103953. PubMed ID: 35325778
[TBL] [Abstract][Full Text] [Related]
10. Lipids, Apolipoproteins, Statins, and Intracerebral Hemorrhage: A Mendelian Randomization Study.
Yu Z; Zhang L; Zhang G; Xia K; Yang Q; Huang T; Fan D
Ann Neurol; 2022 Sep; 92(3):390-399. PubMed ID: 35655417
[TBL] [Abstract][Full Text] [Related]
11. Genetic Association of Lipids and Lipid Drug Targets With Abdominal Aortic Aneurysm: A Meta-analysis.
Harrison SC; Holmes MV; Burgess S; Asselbergs FW; Jones GT; Baas AF; van 't Hof FN; de Bakker PIW; Blankensteijn JD; Powell JT; Saratzis A; de Borst GJ; Swerdlow DI; van der Graaf Y; van Rij AM; Carey DJ; Elmore JR; Tromp G; Kuivaniemi H; Sayers RD; Samani NJ; Bown MJ; Humphries SE
JAMA Cardiol; 2018 Jan; 3(1):26-33. PubMed ID: 29188294
[TBL] [Abstract][Full Text] [Related]
12. Causal association between lipid-lowering drugs and cancers: A drug target Mendelian randomization study.
Ding W; Chen L; Xia J; Pei B; Song B; Li X
Medicine (Baltimore); 2024 May; 103(18):e38010. PubMed ID: 38701318
[TBL] [Abstract][Full Text] [Related]
13. Associations between lipid-lowering drugs and pregnancy and perinatal outcomes: a Mendelian randomization study.
Wang R; Zhao J; Li L; Huo Y
J Hypertens; 2024 Apr; 42(4):727-734. PubMed ID: 38230624
[TBL] [Abstract][Full Text] [Related]
14. Association of lipid-lowering drugs with osteoarthritis outcomes from a drug-target Mendelian randomization study.
Ma W; Chen H; Zhang Z; Xiong Y
PLoS One; 2024; 19(2):e0293960. PubMed ID: 38416763
[TBL] [Abstract][Full Text] [Related]
15. Higher genetically predicted low-density lipoprotein levels increase the renal cancer risk independent of triglycerides and high-density lipoprotein levels: A Mendelian randomization study.
Ma Y; Jian Z; Xiang L; Jin X
Int J Cancer; 2022 Aug; 151(4):518-525. PubMed ID: 35429337
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis.
Richardson TG; Sanderson E; Palmer TM; Ala-Korpela M; Ference BA; Davey Smith G; Holmes MV
PLoS Med; 2020 Mar; 17(3):e1003062. PubMed ID: 32203549
[TBL] [Abstract][Full Text] [Related]
17. Plasma lipids, alcohol intake frequency and risk of Osteoarthritis: a Mendelian randomization study.
Wen MT; Liang XZ; Luo D; Li JC; Yan BZ; Lu BW; Xu B; Li G
BMC Public Health; 2023 Jul; 23(1):1327. PubMed ID: 37434151
[TBL] [Abstract][Full Text] [Related]
18. Genetic variation in targets of lipid-lowering drugs and amyotrophic lateral sclerosis risk: a Mendelian randomization study.
Li Z; Tian M; Jia H; Li X; Liu Q; Zhou X; Li R; Dong H; Liu Y
Amyotroph Lateral Scler Frontotemporal Degener; 2024 Feb; 25(1-2):197-206. PubMed ID: 37688479
[TBL] [Abstract][Full Text] [Related]
19. Plasma lipid levels and risk of retinal vascular occlusion: A genetic study using Mendelian randomization.
Zheng C; Lin Y; Jiang B; Zhu X; Lin Q; Luo W; Tang M; Xie L
Front Endocrinol (Lausanne); 2022; 13():954453. PubMed ID: 36299452
[TBL] [Abstract][Full Text] [Related]
20. Associations between Genetically Proxied Inhibition of Lipid-Lowering Drug Targets and Serum Micronutrients among Individuals of European Descent: A Mendelian Randomization Study.
He JY; Zhang X; Wang K; Lv WQ
J Nutr; 2022 May; 152(5):1283-1290. PubMed ID: 35349717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
